- $9.80bn
- $8.91bn
- $944.61m
Annual income statement for Argan, fiscal year end - January 31st, USD millions except per share, conversion factor applied.
2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | 2026 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 509 | 455 | 573 | 874 | 945 |
| Cost of Revenue | |||||
| Gross Profit | 99.7 | 86.4 | 80.8 | 141 | 194 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 465 | 413 | 537 | 786 | 810 |
| Operating Profit | 44.5 | 41.7 | 36.5 | 88.2 | 135 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 47.1 | 46 | 48.9 | 111 | 161 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 35.7 | 34.7 | 32.4 | 85.5 | 138 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 38.2 | 33.1 | 32.4 | 85.5 | 138 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 38.2 | 33.1 | 32.4 | 85.5 | 138 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.78 | 2.33 | 2.39 | 6.15 | 9.74 |
| Dividends per Share |